CAPR - Capricor Therapeutics to Present Third Quarter 2023 Financial Results and Recent Corporate Update on November 14 | Benzinga
SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases, will release its financial results for the third quarter ended September 30, 2023, after the market close on Tuesday, November 14, 2023. Management will then host a webcast and conference call at 4:30 p.m. ET on November 14.
| Title: |
| Capricor Therapeutics Third Quarter 2023 Financial Results and Recent Corporate Update Conference Call and Webcast |
| Date: |
| Tuesday, November 14, 2023 |
| Time: |
| 4:30 p.m. ET |
| Conference Call Details: |
| Toll-Free: 1-888-886-7786 |